Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
90.34
Dollar change
+0.56
Percentage change
0.62
%
IndexS&P 500 P/E38.83 EPS (ttm)2.33 Insider Own1.60% Shs Outstand601.10M Perf Week4.49%
Market Cap54.44B Forward P/E29.01 EPS next Y3.11 Insider Trans-4.26% Shs Float592.93M Perf Month3.89%
Income1.41B PEG4.12 EPS next Q0.69 Inst Own83.76% Short Float1.62% Perf Quarter4.26%
Sales6.14B P/S8.86 EPS this Y10.43% Inst Trans-0.08% Short Ratio2.92 Perf Half Y35.04%
Book/sh11.82 P/B7.65 EPS next Y12.34% ROA15.38% Short Interest9.63M Perf Year2.74%
Cash/sh2.82 P/C32.00 EPS next 5Y9.44% ROE21.59% 52W Range60.57 - 96.12 Perf YTD18.48%
Dividend Est.- P/FCF200.59 EPS past 5Y15.35% ROI18.14% 52W High-6.01% Beta1.12
Dividend TTM- Quick Ratio2.67 Sales past 5Y10.28% Gross Margin76.11% 52W Low49.15% ATR (14)1.87
Dividend Ex-Date- Current Ratio3.75 EPS Y/Y TTM-3.43% Oper. Margin27.71% RSI (14)58.20 Volatility1.85% 2.13%
Employees19800 Debt/Eq0.10 Sales Y/Y TTM11.68% Profit Margin23.01% Recom2.03 Target Price96.55
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q4.50% Payout0.00% Rel Volume0.69 Prev Close89.78
Sales Surprise1.80% EPS Surprise2.66% Sales Q/Q9.50% EarningsApr 25 AMC Avg Volume3.30M Price90.34
SMA204.05% SMA500.54% SMA20015.06% Trades Volume2,345,993 Change0.62%
Date Action Analyst Rating Change Price Target Change
TodayUpgrade Citigroup Neutral → Buy $98 → $105
May-14-24Upgrade Deutsche Bank Hold → Buy
Mar-07-24Upgrade BofA Securities Neutral → Buy
Feb-02-24Upgrade Wells Fargo Equal Weight → Overweight $94
Jan-04-24Downgrade Evercore ISI Outperform → In-line $80 → $77
Dec-11-23Downgrade Citigroup Buy → Neutral
Nov-28-23Downgrade Wolfe Research Peer Perform → Underperform $57
Sep-26-23Upgrade Oppenheimer Perform → Outperform $90
Jul-19-23Initiated Robert W. Baird Outperform $107
May-30-23Resumed Morgan Stanley Overweight $102
May-14-24 04:33PM
07:53AM
May-13-24 05:52PM
02:20PM
May-08-24 07:21PM
07:52AM Loading…
May-07-24 07:52AM
May-01-24 05:27PM
09:40AM
09:35AM
Apr-30-24 05:03PM
10:20AM
Apr-29-24 02:22PM
12:18PM
07:23AM
Apr-26-24 04:09PM
11:21AM Loading…
11:21AM
11:09AM
10:54AM
10:42AM
10:38AM
10:29AM
09:53AM
08:28AM
03:40AM
Apr-25-24 06:00PM
05:52PM
05:30PM
05:04PM
04:34PM
04:26PM
04:15PM Loading…
04:15PM
Apr-23-24 06:14AM
Apr-22-24 09:16AM
Apr-19-24 01:08AM
Apr-18-24 10:01AM
07:10AM
Apr-17-24 11:01AM
Apr-12-24 04:37AM
Apr-07-24 04:30PM
Mar-26-24 08:02AM
Mar-25-24 09:40AM
Mar-19-24 02:24PM
01:38PM
Mar-15-24 04:02PM
10:50AM
Mar-13-24 11:57AM
Mar-11-24 02:00PM
Mar-07-24 04:57PM
11:31AM
Mar-06-24 09:43AM
Feb-26-24 11:54AM
Feb-23-24 07:05AM
Feb-18-24 01:26PM
Feb-15-24 09:36AM
Feb-13-24 12:09AM
Feb-09-24 02:21AM
Feb-07-24 04:11PM
11:19AM
10:31AM
09:06AM
05:54AM
Feb-06-24 07:55PM
06:00PM
05:25PM
04:54PM
04:44PM
04:40PM
04:15PM
07:18AM
Feb-02-24 07:00AM
06:27AM
Feb-01-24 09:15AM
07:44AM
Jan-30-24 07:05AM
06:15AM
Jan-23-24 07:07AM
Jan-19-24 11:26AM
Jan-16-24 01:20AM
Jan-03-24 07:40AM
Jan-02-24 09:00AM
Dec-20-23 05:24AM
Dec-14-23 07:49PM
Dec-11-23 12:27PM
Dec-08-23 05:11AM
Dec-07-23 05:00PM
08:30AM
Nov-26-23 05:56AM
Nov-25-23 06:58AM
Nov-24-23 11:31AM
Nov-23-23 06:06AM
Oct-30-23 11:40AM
Oct-27-23 07:30AM
Oct-26-23 06:15PM
03:06PM
02:00PM
11:33AM
11:17AM
11:12AM
10:08AM
07:23AM
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ullem Scott B.CVP, Chief Financial OfficerMay 21 '24Option Exercise45.285,625254,68136,186May 21 05:09 PM
Ullem Scott B.CVP, Chief Financial OfficerMay 21 '24Sale90.455,625508,80330,561May 21 05:09 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMay 10 '24Option Exercise45.285,000226,38452,750May 13 05:45 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMay 10 '24Sale87.815,000439,03847,750May 13 05:45 PM
Lippis Daniel J.CVP, JAPACMay 07 '24Option Exercise36.7585731,49525,333May 09 07:40 PM
Lippis Daniel J.CVP, JAPACMay 07 '24Sale85.6085773,35923,890May 09 07:40 PM
Zovighian Bernard JCEOMay 06 '24Buy85.7458049,7533,268May 07 05:53 PM
Chopra DaveenCVP, TMTTMay 04 '24Option Exercise0.004,713027,172May 06 07:17 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMay 04 '24Option Exercise0.005,855045,144May 06 07:16 PM
Ullem Scott B.CVP, Chief Financial OfficerMay 04 '24Option Exercise0.007,465025,905May 06 07:18 PM
Szyman Catherine M.CVP, Critical CareMay 04 '24Option Exercise0.005,796049,018May 06 07:18 PM
Lemercier Jean-Luc MCVP, EMEACLA and JAPACMay 04 '24Option Exercise0.004,1570177,969May 06 07:18 PM
Wood Larry LGlobal President TAVR & SurgMay 04 '24Option Exercise0.006,6750220,022May 06 07:17 PM
Zovighian Bernard JCEOMay 04 '24Option Exercise0.006,265050,554May 07 05:53 PM
MUSSALLEM MICHAEL ADirectorMay 02 '24Option Exercise36.7529,3501,078,61233,836May 02 06:05 PM
MUSSALLEM MICHAEL ADirectorMay 02 '24Sale84.7729,3502,487,9664,486May 02 06:05 PM
Lemercier Jean-Luc MCVP, EMEACLA and JAPACMay 01 '24Option Exercise36.7514,400529,200188,249May 01 05:17 PM
Lemercier Jean-Luc MCVP, EMEACLA and JAPACMay 01 '24Sale84.2114,4001,212,687173,849May 01 05:17 PM
Ullem Scott B.CVP, Chief Financial OfficerApr 30 '24Option Exercise36.757,250266,43826,324Apr 30 04:56 PM
Ullem Scott B.CVP, Chief Financial OfficerApr 30 '24Sale85.807,250622,06219,074Apr 30 04:56 PM
Lippis Daniel J.CVP, JAPACApr 09 '24Option Exercise36.7585731,49518,345Apr 09 05:33 PM
Lippis Daniel J.CVP, JAPACApr 09 '24Sale92.3485779,13517,488Apr 09 05:33 PM
Lemercier Jean-Luc MCVP, EMEACLAApr 08 '24Option Exercise36.7514,400529,200188,249Apr 08 05:10 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentApr 08 '24Option Exercise36.7512,500459,37552,268Apr 08 05:10 PM
Lemercier Jean-Luc MCVP, EMEACLAApr 08 '24Sale92.3214,4001,329,472173,849Apr 08 05:10 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentApr 08 '24Sale92.3312,5001,154,14239,768Apr 08 05:10 PM
MUSSALLEM MICHAEL ADirectorApr 04 '24Option Exercise36.7529,3501,078,61233,836Apr 04 06:26 PM
MUSSALLEM MICHAEL ADirectorApr 04 '24Sale92.4229,3502,712,4184,486Apr 04 06:26 PM
Ullem Scott B.CVP, Chief Financial OfficerApr 01 '24Option Exercise36.757,255266,62126,329Apr 01 06:55 PM
Ullem Scott B.CVP, Chief Financial OfficerApr 01 '24Sale94.897,255688,42319,074Apr 01 06:55 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMar 13 '24Option Exercise36.7514,500532,87554,003Mar 13 05:44 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMar 13 '24Sale91.0114,5001,319,69639,503Mar 13 05:44 PM
Lemercier Jean-Luc MCVP, EMEACLA and JAPACMar 11 '24Option Exercise36.7514,400529,200187,984Mar 11 06:00 PM
Lemercier Jean-Luc MCVP, EMEACLA and JAPACMar 11 '24Sale91.6814,4001,320,149173,584Mar 11 06:00 PM
Lippis Daniel J.CVP, JAPACMar 07 '24Option Exercise36.751,71563,02618,928Mar 07 06:22 PM
Lippis Daniel J.CVP, JAPACMar 07 '24Sale90.981,715156,03117,213Mar 07 06:22 PM
MUSSALLEM MICHAEL ADirectorMar 04 '24Option Exercise36.7529,3501,078,61233,836Mar 04 07:16 PM
MUSSALLEM MICHAEL ADirectorMar 04 '24Sale86.6729,3502,543,7374,486Mar 04 07:16 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 29 '24Option Exercise36.757,255266,62126,329Feb 29 05:12 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 29 '24Sale85.597,255620,92319,074Feb 29 05:12 PM
GALLAHUE KIERANDirectorFeb 23 '24Option Exercise36.867,056260,10710,757Feb 26 05:52 PM
GALLAHUE KIERANDirectorFeb 23 '24Sale87.613,058267,91167,219Feb 26 05:52 PM
Chopra DaveenCVP, TMTTFeb 21 '24Option Exercise59.267,000414,79730,950Feb 21 05:52 PM
Chopra DaveenCVP, TMTTFeb 21 '24Sale86.748,200711,27222,750Feb 21 05:52 PM
Szyman Catherine M.CVP, Critical CareFeb 15 '24Option Exercise36.7527,000992,25061,814Feb 15 05:25 PM
Szyman Catherine M.CVP, Critical CareFeb 15 '24Sale85.6227,0002,311,65434,814Feb 15 05:25 PM
Szyman Catherine M.CVP, Critical CareFeb 13 '24Option Exercise36.7520,000735,00054,814Feb 15 05:25 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentFeb 13 '24Option Exercise36.7511,000404,25050,503Feb 13 04:51 PM
Szyman Catherine M.CVP, Critical CareFeb 13 '24Sale86.4620,0001,729,20034,814Feb 15 05:25 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentFeb 13 '24Sale85.8311,000944,15539,503Feb 13 04:51 PM
SELLERS ROBERT W.A.SVP, Corporate ControllerFeb 12 '24Option Exercise36.7512,210448,71825,297Feb 12 05:44 PM
SELLERS ROBERT W.A.SVP, Corporate ControllerFeb 12 '24Sale87.0012,2101,062,27013,087Feb 12 05:44 PM
STONE HEISZ LESLIEDirectorFeb 08 '24Option Exercise36.867,056260,10734,036Feb 08 06:08 PM
STONE HEISZ LESLIEDirectorFeb 08 '24Sale86.457,056609,99126,980Feb 08 06:08 PM
MUSSALLEM MICHAEL ADirectorFeb 05 '24Option Exercise36.7529,3501,078,61233,836Feb 05 06:37 PM
MUSSALLEM MICHAEL ADirectorFeb 05 '24Sale87.4929,3502,567,7544,486Feb 05 06:37 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 01 '24Option Exercise36.757,255266,62126,503Feb 01 05:52 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 01 '24Sale78.297,255567,99419,248Feb 01 05:52 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJan 12 '24Option Exercise36.7510,000367,50049,503Jan 12 05:36 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJan 12 '24Sale75.6710,000756,70039,503Jan 12 05:36 PM
MUSSALLEM MICHAEL ADirectorJan 05 '24Option Exercise36.7529,3501,078,61233,836Jan 05 07:19 PM
MUSSALLEM MICHAEL ADirectorJan 05 '24Sale72.9829,3502,142,0894,486Jan 05 07:19 PM
Ullem Scott B.CVP, Chief Financial OfficerDec 29 '23Option Exercise36.7514,510533,24233,758Dec 29 04:25 PM
Ullem Scott B.CVP, Chief Financial OfficerDec 29 '23Sale76.5514,5101,110,79419,248Dec 29 04:25 PM
Chopra DaveenCVP, TMTTDec 15 '23Option Exercise59.267,000414,79730,950Dec 15 05:22 PM
Chopra DaveenCVP, TMTTDec 15 '23Sale78.257,000547,72423,950Dec 15 05:22 PM
MUSSALLEM MICHAEL ADirectorDec 13 '23Option Exercise36.7529,3501,078,61233,836Dec 13 07:04 PM
Wood Larry LGlobal President TAVR & SurgDec 13 '23Option Exercise45.288,658392,006222,452Dec 13 07:04 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentDec 13 '23Option Exercise36.758,000294,00047,503Dec 13 07:04 PM
MUSSALLEM MICHAEL ADirectorDec 13 '23Sale74.6229,3502,190,0434,486Dec 13 07:04 PM
Wood Larry LGlobal President TAVR & SurgDec 13 '23Sale71.868,658622,164213,794Dec 13 07:04 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentDec 13 '23Sale71.868,000574,88039,503Dec 13 07:04 PM
Chopra DaveenCVP, TMTTDec 06 '23Option Exercise59.263,500207,39827,450Dec 06 05:01 PM
Chopra DaveenCVP, TMTTDec 06 '23Sale70.003,500245,00623,950Dec 06 05:01 PM
Wood Larry LGlobal President TAVR & SurgNov 13 '23Option Exercise45.288,660392,096222,454Nov 13 05:21 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentNov 13 '23Option Exercise36.756,000220,50045,503Nov 13 05:21 PM
Wood Larry LGlobal President TAVR & SurgNov 13 '23Sale65.308,660565,460213,794Nov 13 05:21 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentNov 13 '23Sale65.306,000391,78039,503Nov 13 05:21 PM
MUSSALLEM MICHAEL ADirectorNov 03 '23Option Exercise36.7529,3501,078,61233,836Nov 06 06:33 PM
MUSSALLEM MICHAEL ADirectorNov 03 '23Sale67.1829,3501,971,7334,486Nov 06 06:33 PM
Ullem Scott B.CVP, Chief Financial OfficerOct 31 '23Option Exercise36.757,255266,62126,503Oct 31 05:22 PM
Ullem Scott B.CVP, Chief Financial OfficerOct 31 '23Sale62.667,255454,56919,248Oct 31 05:22 PM
Wood Larry LGlobal President TAVR & SurgOct 13 '23Option Exercise45.288,660392,096222,454Oct 13 05:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentOct 13 '23Option Exercise36.755,000183,75044,503Oct 13 05:01 PM
Wood Larry LGlobal President TAVR & SurgOct 13 '23Sale70.008,660606,198213,794Oct 13 05:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentOct 13 '23Sale69.985,000349,90939,503Oct 13 05:01 PM
Szyman Catherine M.CVP, Critical CareOct 10 '23Option Exercise36.755,000183,75039,814Oct 10 06:23 PM
Szyman Catherine M.CVP, Critical CareOct 10 '23Sale72.685,000363,40034,814Oct 10 06:23 PM
Chopra DaveenCVP, TMTTOct 03 '23Option Exercise59.268,500503,68232,450Oct 03 04:58 PM
Chopra DaveenCVP, TMTTOct 03 '23Sale70.008,500595,00023,950Oct 03 04:58 PM
MUSSALLEM MICHAEL ADirectorOct 02 '23Option Exercise36.7529,3501,078,61233,836Oct 02 06:51 PM
MUSSALLEM MICHAEL ADirectorOct 02 '23Sale68.8429,3502,020,4544,486Oct 02 06:51 PM
Ullem Scott B.CVP, Chief Financial OfficerSep 29 '23Option Exercise36.757,255266,62126,503Sep 29 04:49 PM
Ullem Scott B.CVP, Chief Financial OfficerSep 29 '23Sale69.547,255504,52719,248Sep 29 04:49 PM
Wood Larry LGlobal President TAVR & SurgSep 14 '23Option Exercise45.288,660392,096222,454Sep 14 08:00 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSep 14 '23Option Exercise36.754,500165,37544,003Sep 14 08:00 PM
Wood Larry LGlobal President TAVR & SurgSep 14 '23Sale73.638,660637,615213,794Sep 14 08:00 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSep 14 '23Sale73.714,500331,69539,503Sep 14 08:00 PM
Szyman Catherine M.CVP, Critical CareSep 08 '23Option Exercise36.755,000183,75039,814Sep 08 05:29 PM
Szyman Catherine M.CVP, Critical CareSep 08 '23Sale76.005,000380,00034,814Sep 08 05:29 PM